Sign in

Trial result ·

Efficacy and Safety of Ecopipam for Tourette Syndrome: A Phase 3 Randomized Clinical Trial.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This trial tested a drug called ecopipam in people with Tourette syndrome. People aged 6 years and up took part at 77 sites in 12 countries. First, all 216 people knew they were taking ecopipam, for 12 weeks. Those whose tics eased were then put into groups by chance. One group kept taking ecopipam, and the other slowly moved to a dummy pill. For 12 more weeks, neither the people nor the staff knew who got which.

What they found

In young people aged 6 to 18, ecopipam lowered the risk of tics coming back. This was compared with the dummy pill, in 90 young people. The authors found this gap was not likely due to chance. In 14 adults, the effect pointed the same way but was not clear. Common side effects were sleepiness, worry, headache, poor sleep, tics and tiredness. The drug did not change weight or mental health scores in a meaningful way. No movement problems caused by the drug were seen.

What it means for patients

The authors say ecopipam kept tic gains in place for up to 24 weeks. They say people coped well with the drug. Side effects mostly touched the brain and nerves.

Why it is not certain yet

Only 14 adults were in the second part, so adult results are unclear. The trial lasted up to 24 weeks, so longer effects are not known. Only people whose tics eased in the first part went on. So the second part shows results only for these people. The first part had no dummy pill group to compare with.

The registered trial

The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.

Source

Efficacy and Safety of Ecopipam for Tourette Syndrome: A Phase 3 Randomized Clinical Trial.

PubMed · PMID 42189524

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Tourette syndrome publications